Antipsychotic maintenance treatment in schizophrenia and the importance of preventing relapse.
作者信息
Emsley Robin
机构信息
Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
出版信息
World Psychiatry. 2018 Jun;17(2):168-169. doi: 10.1002/wps.20521.
Abstract
摘要
相似文献
1
Antipsychotic maintenance treatment in schizophrenia and the importance of preventing relapse.精神分裂症的抗精神病药物维持治疗及预防复发的重要性。
World Psychiatry. 2018 Jun;17(2):168-169. doi: 10.1002/wps.20521.
2
Intermittent drug techniques for schizophrenia.精神分裂症的间歇性给药技术。
Cochrane Database Syst Rev. 2013 Jul 20;2013(7):CD006196. doi: 10.1002/14651858.CD006196.pub2.
3
A randomized, controlled trial of omega-3 fatty acids plus an antioxidant for relapse prevention after antipsychotic discontinuation in first-episode schizophrenia.一项关于ω-3脂肪酸加抗氧化剂用于首发精神分裂症患者停用抗精神病药物后预防复发的随机对照试验。
Schizophr Res. 2014 Sep;158(1-3):230-5. doi: 10.1016/j.schres.2014.06.004. Epub 2014 Jul 2.
4
Maintenance treatment with antipsychotic drugs for schizophrenia.使用抗精神病药物对精神分裂症进行维持治疗。
Cochrane Database Syst Rev. 2012 May 16(5):CD008016. doi: 10.1002/14651858.CD008016.pub2.
5
Continuing, reducing, switching, or stopping antipsychotics in individuals with schizophrenia-spectrum disorders who are clinically stable: a systematic review and network meta-analysis.继续、减少、转换或停止处于临床稳定的精神分裂症谱系障碍个体的抗精神病药物：系统评价和网络荟萃分析。
Lancet Psychiatry. 2022 Aug;9(8):614-624. doi: 10.1016/S2215-0366(22)00158-4. Epub 2022 Jun 23.
6
Impact of paliperidone palmitate one-month formulation on relapse prevention in patients with schizophrenia: A post-hoc analysis of a one-year, open-label study stratified by medication adherence.棕榈酸帕利哌酮单月制剂对精神分裂症患者复发预防的影响：一项为期一年、开放性研究的事后分析，按药物依从性分层。
J Psychopharmacol. 2018 Jun;32(6):691-701. doi: 10.1177/0269881118772449. Epub 2018 May 16.
7
Maintenance Treatment With Antipsychotic Drugs in Schizophrenia: A Cochrane Systematic Review and Meta-analysis.精神分裂症的抗精神病药物维持治疗：一项 Cochrane 系统评价和荟萃分析。
Schizophr Bull. 2022 Jun 21;48(4):738-740. doi: 10.1093/schbul/sbac041.
8
Relapse rates following antipsychotic discontinuation in the maintenance phase after first-episode of schizophrenia: Results of a long-term follow-up study.首发精神分裂症维持期抗精神病药物停药后复发率：一项长期随访研究的结果。
Schizophr Res. 2020 Nov;225:31-38. doi: 10.1016/j.schres.2019.10.015. Epub 2019 Oct 22.
9
Definitions of relapse in trials comparing antipsychotic maintenance with discontinuation or reduction for schizophrenia spectrum disorders: A systematic review.比较抗精神病药物维持治疗与精神分裂症谱系障碍停药或减量的试验中复发的定义：系统评价。
Schizophr Res. 2020 Nov;225:47-54. doi: 10.1016/j.schres.2019.08.035. Epub 2019 Oct 8.
10
A review on schizophrenia and relapse--a quest for user-friendly psychopharmacotherapy.关于精神分裂症与复发的综述——寻求便于使用的精神药物治疗方法
Hum Psychopharmacol. 2014 Sep;29(5):414-26. doi: 10.1002/hup.2421.
引用本文的文献
1
Disability and Adverse Effects of Oral Versus Long-Acting Injectable Antipsychotics in Schizophrenia-Spectrum and Bipolar Disorder: A Comparison Based on Data-Driven Taxonomy.精神分裂症谱系障碍和双相情感障碍中口服和长效注射抗精神病药的残疾和不良反应：基于数据驱动分类的比较。
Clin Drug Investig. 2024 Sep;44(9):715-727. doi: 10.1007/s40261-024-01391-x. Epub 2024 Sep 20.
2
The association between psychosocial stress, interpersonal sensitivity, social withdrawal and psychosis relapse: a systematic review.心理社会应激、人际敏感性、社交退缩与精神病复发之间的关联：一项系统综述。
Schizophrenia (Heidelb). 2023 Apr 10;9(1):22. doi: 10.1038/s41537-023-00349-w.
3
The role of shared decision-making in improving adherence to pharmacological treatments in patients with schizophrenia: a clinical review.共同决策在提高精神分裂症患者药物治疗依从性中的作用：一项临床综述
Ann Gen Psychiatry. 2020 Aug 5;19:43. doi: 10.1186/s12991-020-00293-4. eCollection 2020.
4
Progress in Genetic Polymorphisms Related to Lipid Disturbances Induced by Atypical Antipsychotic Drugs.非典型抗精神病药物所致脂质紊乱相关基因多态性的研究进展
Front Pharmacol. 2020 Feb 4;10:1669. doi: 10.3389/fphar.2019.01669. eCollection 2019.
5
Achieving the Lowest Effective Antipsychotic Dose for Patients with Remitted Psychosis: A Proposed Guided Dose-Reduction Algorithm.实现缓解期精神病患者的最低有效抗精神病药物剂量：拟议的指导剂量减少算法。
CNS Drugs. 2020 Feb;34(2):117-126. doi: 10.1007/s40263-019-00682-8.
本文引用的文献
1
What is the risk-benefit ratio of long-term antipsychotic treatment in people with schizophrenia?精神分裂症患者长期使用抗精神病药物治疗的风险效益比是多少？
World Psychiatry. 2018 Jun;17(2):149-160. doi: 10.1002/wps.20516.
2
Predictors for symptom re-exacerbation after targeted stepwise drug discontinuation in first-episode schizophrenia: Results of the first-episode study within the German research network on schizophrenia.首发精神分裂症患者针对性逐步停药后症状再加重的预测因素：德国精神分裂症研究网络中首发研究的结果
Schizophr Res. 2016 Jan;170(1):168-76. doi: 10.1016/j.schres.2015.10.024. Epub 2015 Nov 20.
3
Risk of symptom recurrence with medication discontinuation in first-episode psychosis: a systematic review.首发精神病停药后症状复发的风险：系统综述。
Schizophr Res. 2014 Feb;152(2-3):408-14. doi: 10.1016/j.schres.2013.08.001. Epub 2013 Aug 21.
4
The evidence for illness progression after relapse in schizophrenia.精神分裂症复发后疾病进展的证据。
Schizophr Res. 2013 Aug;148(1-3):117-21. doi: 10.1016/j.schres.2013.05.016. Epub 2013 Jun 5.
5
The nature of relapse in schizophrenia.精神分裂症复发的本质。
BMC Psychiatry. 2013 Feb 8;13:50. doi: 10.1186/1471-244X-13-50.
6
Maintenance treatment with antipsychotic drugs for schizophrenia.使用抗精神病药物对精神分裂症进行维持治疗。
Cochrane Database Syst Rev. 2012 May 16(5):CD008016. doi: 10.1002/14651858.CD008016.pub2.
7
Treatment response after relapse in a placebo-controlled maintenance trial in schizophrenia.精神分裂症安慰剂对照维持试验复发后的治疗反应。
Schizophr Res. 2012 Jun;138(1):29-34. doi: 10.1016/j.schres.2012.02.030. Epub 2012 Mar 23.
8
Remission in schizophrenia: proposed criteria and rationale for consensus.精神分裂症的缓解：共识的提议标准及基本原理
Am J Psychiatry. 2005 Mar;162(3):441-9. doi: 10.1176/appi.ajp.162.3.441.
9
Relapse and rehospitalization during maintenance treatment of schizophrenia. The effects of dose reduction and family treatment.精神分裂症维持治疗期间的复发与再住院。剂量减少及家庭治疗的效果。
Arch Gen Psychiatry. 1997 May;54(5):453-63. doi: 10.1001/archpsyc.1997.01830170079011.
Zotero 插件